GLIPIZIDE Recall D-0202-2025
Description: glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
GLIPIZIDE Recall D-0202-2025 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0202-2025 |
| Event ID | 96033 |
| Brand | GLIPIZIDE |
| Generic Name | GLIPIZIDE |
| Manufacturer | GLIPIZIDE |
| Active Substance | GLIPIZIDE |
| Drug Route | ORAL |
| Distribution | Nationwide in the USA |
| Quantity | 2,028 units (cartons of 30 individual unit doses) |
| Recall Reason | Failed Dissolution Specifications: |
| Drug Classification | Class II |
| Drug Code Info | 20250122 |
| Product NDC | 60687-480 |
| Product NUI | N0000175608 M0020795 |
| Pharma Class (EPC) | Sulfonylurea [EPC] |
| Pharma Class (CS) | Sulfonylurea Compounds [CS] |
| Recall Initiation Date | 20241217 |
| Report Date | 20250122 |
| Classification Date | 20250116 |
| Address | 2550 John Glenn Ave Ste A Columbus, OH 43217-1188 United States |
| Recalling Firm | Amerisource Health Services LLC |
| Initial Notification | Letter |
| Unique Ingredient Identifier | X7WDT95N5C |
| Drug Application Number | ANDA206928 |
| Structured Product Labeling (SPL ID) | 00b5027a-4427-16fd-e063-6294a90a4a13 |
| Structured Product Labeling (SPL Set ID) | 9cc4b247-d211-4b5e-ba2c-b68848631c2a |
| Similar To |